echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Ruike Biotechnology obtained the New Crown Vaccine "Drug Production License" issued by the Jiangsu Provincial Food and Drug Administration

    Ruike Biotechnology obtained the New Crown Vaccine "Drug Production License" issued by the Jiangsu Provincial Food and Drug Administration

    • Last Update: 2021-12-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Taizhou, November 17, 2021/PRNewswire/ - Jiangsu Ruike Biotechnology Co.


    The new crown vaccine and adjuvant production base established by Ruike Biotech in Taizhou, Jiangsu Province is constructed in accordance with the current international GMP standards.


    In the past 10 years, new adjuvant technologies have gradually emerged in the vaccine industry and are bringing profound changes to the industry


    About Recombinant Two-Component New Coronary Pneumonia Vaccine (ReCOV)

    In May 2020, Ruike Biotechnology cooperated with Jiangsu Province CDC and Taizhou Medical Park Management Committee to jointly develop a recombinant two-component COVID-19 vaccine (CHO cell)


    About Ruike Bio

    Ruike Biotechnology is an innovative vaccine company founded in 2011.


    The information published in this press release may contain certain forward-looking statements


    These forward-looking statements are based on the current views, assumptions, expectations, estimates, forecasts and understandings of the company’s management on future affairs at the time the statement is made


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.